Collaboration for Evidence‐based Practice and Research in Anaesthesia (CEPRA): A consortium initiative for perioperative research

Evidence in perioperative care is insufficient. There is an urgent need for large perioperative research programmes, including pragmatic randomised trials, testing daily clinical treatments and unanswered question, thereby providing solid evidence for effects of interventions given to a large and growing number of patients undergoing surgery and anaesthesia. This may be achieved through large collaborations. Collaboration for Evidence‐based Practice and Research in Anaesthesia (CEPRA) is a novel collaborative research network founded to pursue evidence‐based answers to major clinical questions in perioperative medicine. The aims of CEPRA are to (1) improve clinical treatment and outcomes and optimise the use of resources for patients undergoing anaesthesia and perioperative care, and (2) disseminate results and inform caretakers, patients and relatives, and policymakers of evidence‐based treatments in anaesthesia and perioperative medicine. CEPRA is inclusive in its concept. We aim to extend our collaboration with all relevant clinical collaborators and patient associations and representatives. Although initiated in Denmark, CEPRA seeks to develop an international network infrastructure, for example, with other Nordic countries. The work of CEPRA will follow the highest methodological standards. The organisation aims to structure and optimise any element of the research collaboration to reduce economic costs and harness benefits from well‐functioning research infrastructure. This includes successive continuation of trials, harmonisation of outcomes, and alignment of data management systems. This paper presents the initiation and visions of the CEPRA network. CEPRA aims to be inclusive, patient‐focused, methodologically sound, and to optimise all aspects of research logistics. This will translate into faster research conduct, reliable results, and accelerated clinical implementation of results, thereby benefiting millions of patients whilst being cost and labour‐saving.

[1]  A. Van Zundert,et al.  Funding sources of research articles published in anaesthesia journals over 10 years. , 2022, European journal of anaesthesiology.

[2]  C. Callaway,et al.  Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest. , 2021, The New England journal of medicine.

[3]  S. Jaber,et al.  Effect of dexamethasone on complications or all cause mortality after major non-cardiac surgery: multicentre, double blind, randomised controlled trial , 2021, BMJ.

[4]  L. Glance,et al.  Levels of Evidence Supporting the North American and European Perioperative Care Guidelines for Anesthesiologists between 2010 and 2020: A Systematic Review , 2021, Anesthesiology.

[5]  L. Denehy,et al.  Efficacy of Prehabilitation Including Exercise on Postoperative Outcomes Following Abdominal Cancer Surgery: A Systematic Review and Meta-Analysis , 2021, Frontiers in Surgery.

[6]  L. Fleisher,et al.  Anesthesiologists’ Role in Value-based Perioperative Care and Healthcare Transformation , 2021, Anesthesiology.

[7]  A. Sutton,et al.  Methodologies for systematic reviews with meta-analysis of randomised clinical trials in pain, anaesthesia, and perioperative medicine. , 2021, British journal of anaesthesia.

[8]  M. Schumacher,et al.  A Comprehensive Estimation of the Costs of 30-Day Postoperative Complications Using Actual Costs from Multiple, Diverse Hospitals. , 2020, Joint Commission journal on quality and patient safety.

[9]  J. Anhøj,et al.  A systematic review of pain outcomes reported by randomised trials of hip and knee arthroplasty , 2020, Anaesthesia.

[10]  A. Cavalcanti,et al.  Hydroxyethyl Starch for Fluid Replacement Therapy in High-Risk Surgical Patients: Context and Caution. , 2020, JAMA.

[11]  S. Jaber,et al.  Effect of Hydroxyethyl Starch vs Saline for Volume Replacement Therapy on Death or Postoperative Complications Among High-Risk Patients Undergoing Major Abdominal Surgery: The FLASH Randomized Clinical Trial. , 2020, JAMA.

[12]  John A. Kellum,et al.  Perioperative Quality Initiative consensus statement on intraoperative blood pressure, risk and outcomes for elective surgery , 2019, British journal of anaesthesia.

[13]  A. Hoeft,et al.  Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study. , 2019, The Lancet. Respiratory medicine.

[14]  K. Leslie,et al.  Period-dependent Associations between Hypotension during and for Four Days after Noncardiac Surgery and a Composite of Myocardial Infarction and Death: A Substudy of the POISE-2 Trial , 2017, Anesthesiology.

[15]  P. L. Petersen,et al.  Benefit and harm of pregabalin in acute pain treatment: a systematic review with meta-analyses and trial sequential analyses , 2017, British journal of anaesthesia.

[16]  N. Demartines,et al.  In-hospital clinical outcomes after upper gastrointestinal surgery: Data from an international observational study. , 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[17]  J. Wetterslev,et al.  Post‐operative serious adverse events in a mixed surgical population – a retrospective register study , 2016, Acta anaesthesiologica Scandinavica.

[18]  P. L. Petersen,et al.  Gabapentin for post‐operative pain management – a systematic review with meta‐analyses and trial sequential analyses , 2016, Acta anaesthesiologica Scandinavica.

[19]  L. Feldman,et al.  Enhanced Recovery After Surgery (ERAS) for gastrointestinal surgery, part 2: consensus statement for anaesthesia practice , 2015, Acta anaesthesiologica Scandinavica.

[20]  L. Feldman,et al.  Enhanced Recovery After Surgery (ERAS) for gastrointestinal surgery, part 1: pathophysiological considerations , 2015, Acta anaesthesiologica Scandinavica.

[21]  Brij Mohan,et al.  Anesthesiologist: The silent force behind the scene , 2015, Anesthesia, essays and researches.

[22]  Tej D. Azad,et al.  Estimate of the global volume of surgery in 2012: an assessment supporting improved health outcomes , 2015, The Lancet.

[23]  T. Miller,et al.  Pathophysiology of major surgery and the role of enhanced recovery pathways and the anesthesiologist to improve outcomes. , 2015, Anesthesiology clinics.

[24]  P. L. Petersen,et al.  Postoperative pain treatment after total hip arthroplasty: a systematic review , 2015, Pain.

[25]  Paolo Pelosi,et al.  Mortality after surgery in Europe: a 7 day cohort study , 2012, The Lancet.

[26]  J. Tenhunen,et al.  Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. , 2012, The New England journal of medicine.

[27]  G. Guyatt,et al.  Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. , 2012, JAMA.

[28]  D. Moher,et al.  CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials , 2010, BMJ : British Medical Journal.

[29]  D. Moher,et al.  CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials , 2010, BMJ : British Medical Journal.

[30]  Henrik Kehlet,et al.  Anaesthesia, surgery, and challenges in postoperative recovery , 2003, The Lancet.